Literature DB >> 1629219

Bovine bone activin enhances bone morphogenetic protein-induced ectopic bone formation.

Y Ogawa1, D K Schmidt, R M Nathan, R M Armstrong, K L Miller, S J Sawamura, J M Ziman, K L Erickson, E R de Leon, D M Rosen.   

Abstract

A 25-kDa homodimeric protein was purified from demineralized bovine bone extract and identified as activin A. The bovine bone activin enhanced formation of ectopic bone in rat subcutis when implanted in combination with partially purified bovine bone morphogenetic protein (BMP-2, BMP-3) in collagen/ceramic carrier. The implants, removed at 14 days, contained markedly elevated levels of alkaline phosphatase activity. Histological examination revealed an extensive formation of woven bone with very little cartilage. In contrast, a combination of transforming growth factor-beta 2 and BMP promoted formation of bone with an abundance of cartilage. The implants with BMP alone exhibited some osteoinductive activity, while the implants with activin alone showed no activity. These results demonstrate that bone is a rich source of activin and that activin plays an important role in modulating bone formation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1629219

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

Review 1.  Three dimensional de novo micro bone marrow and its versatile application in drug screening and regenerative medicine.

Authors:  Guanqun Li; Xujun Liu; Qian Du; Mei Gao; Jing An
Journal:  Exp Biol Med (Maywood)       Date:  2015-08

2.  Activin A suppresses osteoblast mineralization capacity by altering extracellular matrix (ECM) composition and impairing matrix vesicle (MV) production.

Authors:  Rodrigo D A M Alves; Marco Eijken; Karel Bezstarosti; Jeroen A A Demmers; Johannes P T M van Leeuwen
Journal:  Mol Cell Proteomics       Date:  2013-06-17       Impact factor: 5.911

Review 3.  TGF-β Family Signaling in Connective Tissue and Skeletal Diseases.

Authors:  Elena Gallo MacFarlane; Julia Haupt; Harry C Dietz; Eileen M Shore
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-11-01       Impact factor: 10.005

4.  Activation of signalling by the activin receptor complex.

Authors:  L Attisano; J L Wrana; E Montalvo; J Massagué
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

5.  Skeletal Response to Soluble Activin Receptor Type IIB in Mouse Models of Osteogenesis Imperfecta.

Authors:  Youngjae Jeong; Salah A Daghlas; Yixia Xie; Molly A Hulbert; Ferris M Pfeiffer; Mark R Dallas; Catherine L Omosule; R Scott Pearsall; Sarah L Dallas; Charlotte L Phillips
Journal:  J Bone Miner Res       Date:  2018-06-22       Impact factor: 6.741

6.  Bone morphogenetic protein receptors and activin receptors are highly expressed in ossified ligament tissues of patients with ossification of the posterior longitudinal ligament.

Authors:  K Yonemori; T Imamura; Y Ishidou; T Okano; S Matsunaga; H Yoshida; M Kato; T K Sampath; K Miyazono; P ten Dijke; T Sakou
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

Review 7.  The Activin Social Network: Activin, Inhibin, and Follistatin in Breast Development and Cancer.

Authors:  Darcie D Seachrist; Ruth A Keri
Journal:  Endocrinology       Date:  2019-05-01       Impact factor: 4.736

8.  Activin A expression regulates multipotency of mesenchymal progenitor cells.

Authors:  Farida Djouad; Wesley M Jackson; Brent E Bobick; Sasa Janjanin; Yingjie Song; George T J Huang; Rocky S Tuan
Journal:  Stem Cell Res Ther       Date:  2010-05-04       Impact factor: 6.832

Review 9.  Regulation of osteoblastogenesis and osteoclastogenesis by the other reproductive hormones, Activin and Inhibin.

Authors:  Kristy M Nicks; Daniel S Perrien; Nisreen S Akel; Larry J Suva; Dana Gaddy
Journal:  Mol Cell Endocrinol       Date:  2009-07-15       Impact factor: 4.102

10.  A soluble activin type IIA receptor induces bone formation and improves skeletal integrity.

Authors:  R Scott Pearsall; Ernesto Canalis; Milton Cornwall-Brady; Kathryn W Underwood; Brendan Haigis; Jeffrey Ucran; Ravindra Kumar; Eileen Pobre; Asya Grinberg; Eric D Werner; Vaida Glatt; Lisa Stadmeyer; Deanna Smith; Jasbir Seehra; Mary L Bouxsein
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.